Steve Hach's  Instablog

Steve Hach
Send Message
Steve Hach is the Senior Editor at ValuEngine.com, a Newtown, Pennsylvania-based stock valuation and forecast service. ValuEngine utilizes Ivy League financial research as the basis for its coverage of more than 7000 US, Japanese, and Canadian, and other foreign stocks. Hach utilizes... More
My company:
ValuEngine
  • Health Care Leaders Ranked And Rated By ValuEngine.com 0 comments
    Jan 17, 2014 3:12 PM | about stocks: CLSN, PLX, WST, USNA, RHHBY, MNK, ANTM, HUM, ALNY, ACAD, CTIC, ANTH, CLDX, VZ

    VALUATION WARNING: Our models find that overvaluation is at levels typically seen when market pullbacks occur. Overvalued stocks now make up 85.19% of our stocks assigned a valuation and 53.33% of those equities are calculated to be overvalued by 20% or more. ALL sectors are again calculated to be overvalued--15 of them by double digits.

    ValuEngine Index Overview

     

     

     

     

     

     

     

    Index Week Open Thurs. Close Change % Change YTD
    DJIA 16434.03 16417.01 -17.02 -0.10% -0.96%
    NASDAQ 4167.41 4218.69 51.28 1.23% 1.01%
    RUSSELL 2000 1162.94 1173.13 10.19 0.88% 0.82%
    S&P 500 1841.26 1845.89 4.63 0.25% -0.13%

     

    ValuEngine Market Overview

     

     


     

    Summary of VE Stock Universe
    Stocks Undervalued 14.81%
    Stocks Overvalued 85.19%
    Stocks Undervalued by 20% 4.79%
    Stocks Overvalued by 20% 53.33%
    ValuEngine Sector Overview

     
















     

     

    Sector Change MTD YTD Valuation Last 12-MReturn P/E Ratio
    Medical 0.36% 5.77% 5.77% 38.19% overvalued 45.54% 30.02
    Computer and Technology -0.01% 3.18% 3.18% 36.74% overvalued 37.11% 31.92
    Aerospace 0.04% 3.50% 3.50% 34.01% overvalued 58.07% 19.58
    Multi-Sector Conglomerates -0.09% -0.70% -0.70% 33.65% overvalued 16.11% 20.02
    Transportation -0.12% 0.74% 0.74% 32.52% overvalued 38.36% 22.76
    Consumer Discretionary -0.10% 0.15% 0.15% 32.31% overvalued 41.94% 30.13
    Auto-Tires-Trucks 0.33% 1.56% 1.56% 29.96% overvalued 43.50% 19.98
    Industrial Products -0.01% 1.04% 1.04% 28.93% overvalued 37.13% 23.44
    Business Services -0.03% 0.26% 0.26% 27.41% overvalued 35.28% 26.79
    Retail-Wholesale -0.63% -2.81% -2.81% 24.20% overvalued 33.92% 23.62
    Consumer Staples -0.36% -0.40% -0.40% 23.74% overvalued 24.11% 23.72
    Finance -0.21% 0.04% 0.04% 23.00% overvalued 14.15% 17.97
    Construction -0.07% 1.87% 1.87% 18.13% overvalued 29.29% 25.72
    Oils-Energy 0.38% -0.21% -0.21% 14.16% overvalued 12.88% 26.92
    Utilities -0.15% 1.20% 1.20% 12.66% overvalued 11.22% 20.52
    Basic Materials 0.56% 2.09% 2.09% 11.89% overvalued -23.58% 22.18
    ValuEngine Newsletters Latest Results

     

     


     

     

     

    VE Newsletter Current Results S&P 500 Last Month Total S&P 500 Since Inception S&P 500
    Forecast MNS 1.73 3.64 -2.54 -0.59 109.34 102.06
    Dividend Stock 1.08 1.52 -0.61 0.88 10.14 17.13
    Small Cap Stock 2.28 2.01 -3.01 1.58 34.36 30.48
    View 0.45 1.95 3.52 1.27 96.63 59.89

    ValuEngine's Newsletters Beat the Market

    Free Download for Readers

    As a bonus to our Free Weekly Newsletter subscribers,
    we are offering a FREE DOWNLOAD of one of our Stock Reports

    IBM (NYSE:IBM) is an information technology (NYSE:IT) company. The company operates in five segments: Global Technology Services, Global Business Services, Software, Systems and Technology, and Global Financing. The Global Technology Services segment provides IT infrastructure services and business process services. The Global Business Services segment offers professional services and application management services. The Software segment consists primarily of middleware and operating systems software. The Systems and Technology segment provides computing power and storage solutions; and semiconductor technology products and packaging solutions. The Global Financing segment invests in financing assets, leverages with debt and manages the associated risks. IBM is headquartered in Armonk, New York.

    ValuEngine continues its BUY recommendation on IBM for 2014-01-16. Based on the information we have gathered and our resulting research, we feel that IBH has the probability to OUTPERFORM average market performance for the next year. The company exhibits ATTRACTIVE Company Size and Volatility.

    Read our Detailed Valuation Report, a $25 value, for FREE HERE.

    Sector Talk--Medical

    Below, we present the latest data on Medical stocks from our Institutional software package (Pending:VEI). Top five lists are provided for each category. We applied some basic liquidity criteria--share price greater than $3 and average daily volume in excess of 100k shares.

    Top-Five Medical Stocks--Short-Term Forecast Returns

     

     

     

     

     

     

     

     

    Ticker Name Mkt Price Valuation(%) Last 12-M Retn(%)
    CLSN CELSION CORP 3.99 -74 -89.05
    PLX PROTALIX BIOTHR 4.85 N/A -5.46
    WST WEST PHARM SVC 51.01 -34.44 86.17
    USNA USANA HLTH SCI 59.06 -6.59 59.15
    RHHBY ROCHE HLDG LTD 69.75 N/A 31.67

    Top-Five Medical Stocks--Long-Term Forecast Returns

     

     

     

     

     

     

     

     

    Ticker Name Mkt Price Valuation(%) Last 12-M Retn(%)
    CLSN CELSION CORP 3.99 -74 -89.05
    PLX PROTALIX BIOTHR 4.85 N/A -5.46
    WST WEST PHARM SVC 51.01 -34.44 86.17
    USNA USANA HLTH SCI 59.06 -6.59 59.15
    RHHBY ROCHE HLDG LTD 69.75 N/A 31.67

    Top-Five Medical Stocks--Composite Score

     

     

     

     

     

     

     

     

    Ticker Name Mkt Price Valuation(%) Last 12-M Retn(%)
    QCOR QUESTCOR PHARMA 61.43 -11.38 140.62
    WST WEST PHARM SVC 51.01 -34.44 86.17
    WLP WELLPOINT INC 85.56 4.66 38.33
    USNA USANA HLTH SCI 59.06 -6.59 59.15
    HUM HUMANA INC NEW 96.16 7.33 35.9

    Top-Five Medical Stocks--Most Overvalued

     

     

     

     

     

     

     

     

    Ticker Name Mkt Price Valuation(%) Last 12-M Retn(%)
    ALNY ALNYLAM PHARMA 88.23 300 298.51
    ACAD ACADIA PHARMA 24.26 300 350.09
    CTIC CELL THERAPEUT 3.2 300 123.78
    ANTH ANTHERA PHARMA 3.28 300 -40.59
    CLDX CELLDEX THERAPT 28.59 260.43 287.4

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

    Stocks: CLSN, PLX, WST, USNA, RHHBY, MNK, ANTM, HUM, ALNY, ACAD, CTIC, ANTH, CLDX, VZ
Back To Steve Hach's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.